Enochian Biosciences Long Term Debt

Enochian Biosciences (ENOB) currently reports a long-term debt of $130K as of March 2026. That compares with $500K in the prior-year period — down 73.6% year over year. Use the charts on this page to explore Enochian Biosciences's long-term debt history and peer comparisons.

Enochian Biosciences's long-term debt decreased from $500K to $130K — a 73.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enochian Biosciences reported $130K in long-term debt as of March 2026. That compares with $500K in the prior-year period — down 73.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $130K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enochian Biosciences, and consider following ENOB for alerts when major investors trade the stock.

Enochian Biosciences is classified in the Healthcare sector. On long-term debt, it currently shows $130K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENOB with unrelated industries.